BRPI0411043A - composição medicinal - Google Patents

composição medicinal

Info

Publication number
BRPI0411043A
BRPI0411043A BRPI0411043-9A BRPI0411043A BRPI0411043A BR PI0411043 A BRPI0411043 A BR PI0411043A BR PI0411043 A BRPI0411043 A BR PI0411043A BR PI0411043 A BRPI0411043 A BR PI0411043A
Authority
BR
Brazil
Prior art keywords
optionally substituted
lower alkyl
substituted phenyl
medicinal composition
medical composition
Prior art date
Application number
BRPI0411043-9A
Other languages
English (en)
Inventor
Shuichi Yada
Yuko Oh-Uchi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of BRPI0411043A publication Critical patent/BRPI0411043A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO MEDICINAL". Composição medicinal que compreende: um composto de triazol possuindo uma estrutura representa da pela fórmula geral (I): (I) (na qual Ar¬ 1¬ é fenila opcionalmente substituída; Ar¬ 2¬ é fenila opcionalmente substituída;R¬ 0¬ é hidrogênio; R¬ 1¬ é alquila inferior; R¬ 2¬, R¬ 3¬, R¬ 4¬, e R¬ 5¬ são iguais ou diferentes e cada um é hidrogênio ou alquila inferior; p é 0 ou 1; q, r, e s são cada um 0, 1, ou 2; e A é 1,3-dioxano), um éster farmacologicamente aceitável do composto, ou também um sal farmaceuticamente aceitável do mesmo; e uma substância básica farmacologicamente aceitável.
BRPI0411043-9A 2003-06-06 2004-06-04 composição medicinal BRPI0411043A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003161945 2003-06-06
PCT/JP2004/008170 WO2004108134A1 (ja) 2003-06-06 2004-06-04 トリアゾール化合物を含有する医薬組成物

Publications (1)

Publication Number Publication Date
BRPI0411043A true BRPI0411043A (pt) 2006-07-11

Family

ID=33508652

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411043-9A BRPI0411043A (pt) 2003-06-06 2004-06-04 composição medicinal

Country Status (8)

Country Link
US (1) US20060116411A1 (pt)
EP (1) EP1632228A4 (pt)
KR (1) KR20060015745A (pt)
CN (1) CN1829512B (pt)
BR (1) BRPI0411043A (pt)
CA (1) CA2528493C (pt)
TW (1) TW200503697A (pt)
WO (1) WO2004108134A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602007009489D1 (de) * 2006-02-22 2010-11-11 Eisai R&D Man Co Ltd Stabilisierte pharmazeutische zusammensetzung
CN107049935A (zh) * 2010-06-29 2017-08-18 默沙东公司 取代β‑环糊精稳定的泊沙康唑静脉输注液制剂
CN111481568B (zh) * 2020-04-22 2021-04-02 一力制药(罗定)有限公司 一种铝碳酸镁片及其制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60188330A (ja) * 1984-03-07 1985-09-25 Kotobuki Seiyaku Kk １，３−ジオキサン誘導体を含有する経口薬の製剤方法
RU2146250C1 (ru) * 1995-04-06 2000-03-10 Санкио Компани Лимитед Триазоловые соединения или их фармакологически приемлемые соли и противогрибковая композиция
US6391903B1 (en) * 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
JP3240129B1 (ja) * 1999-09-09 2001-12-17 三共株式会社 トリアゾール抗真菌剤
TW591024B (en) * 2000-03-27 2004-06-11 Sankyo Lifetech Company Ltd An amide type triazole compound having antifungal activity
JP3473952B2 (ja) * 2000-09-13 2003-12-08 三共株式会社 トリアゾール抗真菌剤

Also Published As

Publication number Publication date
KR20060015745A (ko) 2006-02-20
CA2528493C (en) 2009-01-20
CN1829512A (zh) 2006-09-06
WO2004108134A1 (ja) 2004-12-16
CA2528493A1 (en) 2004-12-16
EP1632228A1 (en) 2006-03-08
EP1632228A4 (en) 2006-11-29
TW200503697A (en) 2005-02-01
US20060116411A1 (en) 2006-06-01
CN1829512B (zh) 2010-10-06

Similar Documents

Publication Publication Date Title
ATE306261T1 (de) Antithrombosemittel
ATE297203T1 (de) Antithrombotische mitteln
BRPI0511504A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
SE9904508D0 (sv) New compounds
SE0302760D0 (sv) New compounds
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
AU2003263878A1 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
ATE218345T1 (de) Arzneimittel gegen spinocerebellare degeneration
DE60045508D1 (de) Dalda-analoge und ihre verwendung
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MXPA05013050A (es) Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos.
ATE308540T1 (de) Antithrombosemittel
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
GB0212410D0 (en) Organic compounds
BRPI0411043A (pt) composição medicinal
MXPA05011521A (es) Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.